港交所消息：截至9月30日，瑞银集团持有的药明康德（）H股多头头寸从5.05%降至3.98%

Group 1 - UBS Group's long position in WuXi AppTec's H-shares decreased from 5.05% to 3.98% as of September 30 [1]